Last reviewed · How we verify
NCT05061953
Development of a Novel Functional Eye-Tracking Software Application for Multiple Sclerosis
trial testing Eye-Tracking in Multiple Sclerosis in 168 participants. Currently enrolling.
18 October 2027
Quick facts
| Lead sponsor | Innodem Neurosciences |
|---|---|
| Status | Recruiting now |
| Study type | OBSERVATIONAL |
| Enrollment | 168 |
| Start date | 18 October 2021 |
| Primary completion | 18 October 2027 |
| Estimated completion | 18 October 2027 |
| Sites | 2 locations across Canada |
Drugs / interventions tested
- Eye-Tracking
Conditions studied
- Multiple Sclerosis — all drugs for Multiple Sclerosis →
Sponsor
Innodem Neurosciences
Who can join
18 and older, any sex, with Multiple Sclerosis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study aims to develop and validate a sensitive and non-invasive eye-tracking software application. This study will obtain participant responses to brief cognitive tests designed to evaluate several key functions known to be affected by MS and non-invasive eye movement measurements in response to visually presented stimuli during specifically designed eye-tracking tests. The study data will be used to develop machine learning algorithms and validate a software application intended to track the progressive component of multiple sclerosis and associated cognitive changes.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Oculomotor analysis to assess brain health: preliminary findings from a longitudinal study of multiple sclerosis using novel tablet-based eye-tracking software.
de Villers-Sidani É, Voss P, Bastien N, Cisneros-Franco JM, et al · · 2023 · cited 9× · PMID 37745656 · DOI 10.3389/fneur.2023.1243594
Verify or expand the search:
- PubMed search for NCT05061953
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Eye-Tracking
Trials testing the same drug.
- NCT07110493 — Study of Visual Perception Phenomena: Phosphene Mapping Induced by TMS and Its Relationship With Eye Movements · NA · recruiting
- NCT06283524 — Eye-tracking Investigation of Clinical Measures in Multiple Sclerosis · completed
- NCT06256731 — ETNA-MS Device Validation Study · completed
- NCT05661266 — Investigating Eye-Movement Biomarkers of Disease Severity and Cognition in Multiple Sclerosis · completed
- NCT05176704 — Development and Validation of a Novel Functional Eye-Tracking Software Application for Alzheimer's Disease · unknown
Other recruiting trials for Multiple Sclerosis
Currently open trials in the same condition.
- NCT07507084 — The Effect of Internal- or External-Focused Exercise Training, Administered in Conjunction With a Cognitive Task, on Wal · NA · recruiting
- NCT07524231 — Evaluation of the Effects of Laughter Yoga · NA · recruiting
- NCT07489794 — URINARY INCONTINENCE AND PELVIC FLOOR MUSCLE ACTIVITY IN MULTIPLE SCLEROSIS · recruiting
- NCT07236684 — Identification of Factors Related to UI in Patients With MS and EMG Assessment of PFM Activity · recruiting
- NCT07500727 — Skeletal Muscle Aging and Responsiveness in Aged People With MS · NA · recruiting
Other Innodem Neurosciences trials
Trials by the same sponsor.
- NCT06283524 — Eye-tracking Investigation of Clinical Measures in Multiple Sclerosis · completed
- NCT06256731 — ETNA-MS Device Validation Study · completed
- NCT05661266 — Investigating Eye-Movement Biomarkers of Disease Severity and Cognition in Multiple Sclerosis · completed
- NCT05212727 — Development and Validation of a Novel Functional Eye-Tracking Software Application for Neurological Disorders · terminated
- NCT05176704 — Development and Validation of a Novel Functional Eye-Tracking Software Application for Alzheimer's Disease · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05061953 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Innodem Neurosciences
- Last refreshed: 1 April 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05061953.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing